cetylpyridinium chloride anhydrous has been researched along with Aggressive Natural Killer Cell Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelini, DF; Battistini, L; Borsellino, G; Diamantini, A; Galandrini, R; Micucci, F; Placido, R; Poccia, F; Santoni, A; Semenzato, G; Zambello, R | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Aggressive Natural Killer Cell Leukemia
| Article | Year |
|---|---|
NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease.
Topics: Animals; Clone Cells; Cross-Linking Reagents; Female; Flow Cytometry; Health; Humans; Killer Cells, Natural; Leukemia, Large Granular Lymphocytic; Male; Mice; NK Cell Lectin-Like Receptor Subfamily C; NK Cell Lectin-Like Receptor Subfamily D; Phenotype; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Tissue Donors | 2011 |